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Abstract 
HLA-B27 positivity makes the onset of autoimmune diseases such as Uveitis, 
Ankylosing spondylitis and Crohn’s more likely to occur.  Ankylosing spondylitis 
and Crohn’s disease are two types of HLA-B27 positive diseases that 
demonstrate a direct association with Uveitis.   Although the possession of HLA-
B27 positivity is not mandatory for autoimmune diseases such as Uveitis to occur 
HLA-B27 positivity not only makes it more likely but may modify the clinical 
picture in which a patient presents.  In relation to assessment and diagnosis it is 
imperative that the medical history of patients is thoroughly examined to ensure 
pathological sequelae are appropriately treated.  Nurses play an important role in 
assessing patients that have Uveitis and should suspect Ankylosing spondylitis 
or Crohn’s disease may be present.  
 HLA-B27 Positivity 
A diagnosis of HLA-B27 positivity is the commonest known aetiology associated 
with a number of systemic autoimmune inflammatory diseases (Jones, 2001; 
Cauli et al, 2002; Monnet et al, 2004; Levinson, 2005; Andrews and Lightman, 
2008; Di Lorenzo, 2008; Cox et al, 2008, 2010).  HLA-B27 positivity increases 
the likelihood of developing inflammatory bowel disease, Crohn’s disease, 
ulcerative colitis, ankylosing spoindylitis, Reiter’s syndrome, psoriasis and 
psoriatic arthropathy (Cauli et al, 2002; Di Lorenzo, 2008).  A prominent factor 
involving the axial skeleton tends to HLA-B27 associated arthropathy (Jones, 
2001; Cauli et al, 2002).   Uveitis is a sequelae frequently associated with the 
aforementioned autoimmune diseases.   
 
Not all HLA-B27 positive patients that have Uveitis will be aware that they have 
associated systemic disease.  In addition, patients who are HLA-B27 positive 
who present with these autoimmune diseases may be unaware they are 
predisposed to the development of Uveitis.  Early identification of HLA-B27 
positive diseases; particularly as it relates to the arthropathies is essential as 
early treatment can affect long-term outcome.  The predisposition toward HLA-
B27 positivity is evident in some family groups with a ratio of male to female 
1.5:1.   In relation to Uveitis, it has been noted that 19 – 88% have this HLA 
phenotype depending on the population studied (Di Lorenzo, 2008; Cox et al 
2008, 2010).  Although there are difficulties in studying immunogenetics in 
Uveitis because of the small number of patients and families with the disease 
some progress is being made in relation to HLA-B27 associated Uveitis 
(Levinson, 2005).   
Immunogenetics  
 
HLA-B27 Positivity: associated health implications 
 3 
In 1972, the first human leukocyte antigen (HLA) haplotype association with 
inflammatory disease was identified in which the correlation was made between 
HLA-B27 and ankylosing spondylitis (Di Lorenzo, 2008).  Since 1972 a number of 
studies have linked the human leukocyte antigen (HLA) to other inflammatory 
diseases such as Crohn’s disease. The majority of studies associated with 
Uveitis have described the human leukocyte antigen (HLA) association 
(Levinson, 2005; Di Lorenzo, 2008).  Of patients diagnosed with Uveitis, as much 
as 50 - 60% may be HLA–B27 positive (Di Lorenzo, 2008).  An individual’s 
predisposition to development of disease and associated sequelae can be linked 
to a gene.  The predictive positivity of an allele known to confer risk for disease in 
relation to a blood relative of a patient with Uveitis has not as yet been formally 
established, however research into families with HLA-B27 associated Uveitis 
may provide some useful guidelines that can be used to advise patients and their 
families about Uveitis and associated sequelae (Jones, 2001; Levinson, 2005; Di 
Lorenzo, 2008).   
 
The HLA genes are found on chromosome 6 in the region that has become 
known as the major histocompatability complex (MHC) of the human.  Although 
the MHC contains many genes involved in the immune system, the gene 
products that are primarily responsible for an immune response are known as the 
human leukocyte antigens.  They are characterised by evaluating an individual’s 
serologic reactivity to allogenic leukocytes.  Of particular note is that the HLA 
genes are consistently inherited together from either the maternal or paternal 
chromosome (Levinson, 2005; Cox et al, 2010).  A halotype can only be 
determined with certainty by family studies. 
 
The HLA system has been linked with disease for over 30 years (Levinson, 
2005).  However the precise role of HLA molecules in disease pathogenesis such 
as Crohn’s and Uveitis is still not well established (Levinson, 2005; Kanski, 2007; 
Di Lorenzo, 2008).  It has been noted that microbial pathogens may play a more 
direct role in diseases that are considered due to autoimmunity including HLA 
associated Uveitis. For example, in at least a part of the autoimmune process, it 
is a result of a loss of tolerance to self antigens caused by exposure to 
pathogens which triggers ocular inflammation (Levinson, 2005).  Self antigens are 
protective mechanisms that will occasionally fail for a variety of reasons, any one 
of which or combination therein leads to an autoimmune disease.  For example, 
the pathogen may share some antigenic features with the patient such that an 
immune response against the foreign antigen also causes damage to the 
patient’s cells that have a similar antigen (Jones, 2001). 
  
Uveitis and its Causes   
   
Uveitis can be caused by a number of autoimmune diseases including 
rheumatoid arthritis and ankylosing spondylitis as well as infection and exposure 
to toxins (DoH, 2006; Di Lorenzo, 2008). However, in many cases the cause 
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remains unknown (DoH, 2006).  Uveitis is an inflammation of the uvea (Monnet 
et al, 2004; DoH, 2006). The uveal tract consists of three distinct sections, which 
have some similar and some individual features.  These sections are the iris, the 
ciliary body and the choroid.  One common feature of the three parts of the uveal 
tract is that they contain the main arterial and venous supply to the inner eye as 
well as containing pigment.  Anatomically, Uveitis is classified into either anterior, 
intermediate, posterior or panuveitis (Andrews and Lightman, 2008; Kanski, 
2010). 
 
The blood vessels supplying the choroid/retina and iris are unique in that the 
junctions between the endothelium cells of the capillaries do not allow larger 
molecules to pass through (Forrester et al, 1999). This provides a physical 
barrier between the local blood vessels and the innermost parts of the globe.  
This barrier prevents the blood cells (lymphocytes and erythrocytes) from 
entering the eye where they would interfere with the transparency of the aqueous 
and the vitreous.  It is known as the blood eye barrier and is similar to the blood 
brain barrier.  
 
During the inflammatory response this barrier is compromised and can result in 
blood cells collecting in either the anterior or posterior segment.  The presence of 
lymphocytes (white blood cells and other protein) in the anterior or posterior 
segments of the eye (known as ‘cells and flare’) is almost pathonemonic for the 
condition. The accumulation of cells and other protein causes a decrease in 
vision experienced by patients during acute attacks of Uveitis. 
The most common form of Uveitis is acute anterior Uveitis (AAU), which involves 
inflammation in the front part of the eye. This form of Uveitis is usually limited to 
the iris and ciliary body. This condition is often called iritis (inflammation of the 
iris).  It may typically affect only one eye but can be present in both eyes at the 
same time and has been found to be most common in young and middle-aged 
people. A history of an autoimmune disease is a risk factor and must always be 
taken into consideration during assessment.  HLA-B27 associated AAU accounts 
for 18 – 32% of all cases of anterior Uveitis in Western countries and 6 – 13% of 
all cases of anterior Uveitis in Asia (Di Lorenzo, 2008). 
Another form of Uveitis is pars planitis; also termed peripheral Uveitis.  Pars 
planitis is inflammation of the pars plana, a narrow area between the iris and the 
choroid. Pars planitis usually occurs in young men, age 20 to 40 and is generally 
not associated with any other disease. However, there have been a few case 
reports of an association with Crohn's disease (Kanski, 2007, 2010).  Some 
experts suggest a possible association with multiple sclerosis and sarcoidosis as 
well (Zimmerman, 2004). For this reason, these experts recommend that those 
over 25 years of age diagnosed with pars planitis receive an MRI of their brain 
and spine (DoH, 2006; Kanski, 2009, 2010). 
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Posterior Uveitis affects the posterior segment of the eye and may include 
inflammation of the retina as well as the choroid. This is called choroiditis. If the 
adjacent retina is also involved it is called chorioretinitis.  Anterior, intermediate 
and posterior Uveitis may follow a systemic infection such as a campylobacter 
infection or occur in association with an autoimmune disease such as Ankylosing 
spondylitis or Crohn’s disease. 
In posterior Uveitis the inflammation causes spotty areas of scarring on the 
choroid and retina that result in areas of vision loss. The degree of vision loss 
depends on the amount and location of scarring. If the central part of the retina, 
called the macula, is involved, central vision becomes impaired.  Uveitis can be 
associated with any of the disorders shown in Table 1.  
 Chlamydial infection 
 Bacillary dysentery (Gram-negative organisms including Shigella, 
Salmonella, Campylobacter, Klebsiella and Yersinia species.) 
 Toxoplasmosis  
 Tuberculosis  
 Sarcoidosis  
 Syphilis  
 AIDS  
 CMV retinitis or other cytomegalovirus infection  
 Trauma  
 Ulcerative colitis  
 Kawasaki disease  
 Herpes zoster infection  
 Ankylosing spondylitis  
 Beçhet’s syndrome 
 Psoriasis 
 Reiter’s syndrome 
Table 1 Uveitis Associated Disorders 
Signs and Symptoms of Uveitis     
Symptoms of Uveitis depend on the site of inflammation and whether it is acute 
or chronic.  Chronic Uveitis may be asymptomatic and only discovered on routine 
examination.   
AAU accounts for approximately 75% of all cases of intraocular inflammation 
(Andrews and Lightman, 2008).  AAU usually runs a short course of between 4 to 
12 weeks (Kanski, 2007; Di Lorenzo, 2008).  It has a tendency to affect the same 
eye especially in patients that are HLA-B27 positive however it is known to affect 
both eyes.  AAU classically presents as a triad of pain, redness and photophobia.  
Pain can vary from mild to severe and is thought to be due to iris and ciliary body 
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spasm. Conjunctival injection may be present in the form of a cilliary flush which 
is redness around the limbus of the cornea. Vision may be blurred due to 
inflammatory cells in the anterior chamber and reduced ability to accommodate 
the lens for near vision.  Symptoms evident in AAU are shown in Table 2.   
Ocular manifestations may include: 
 fine keratitic precipitates on the endothelium (Di Lorenzo, 2008). 
 hypopyon which will be seen on detailed examination with a slit lamp 
(Andrews and Lightman, 2008).  
 anterior chamber inflammation with an accumulation of cells and fibrinous 
exudate and synchiae (adhesions between the posterior iris and anterior 
lens capsule).   
Generally complications of AAU include cataract, glaucoma, hypotony and 
cystoid macular oedema (Kanski, 2007; Di Lorenzo, 2008).  Symptoms may 
develop rapidly and early attention of an ophthalmologist is critical in treating the 
disorder (DoH, 2006; Kanski, 2007; Cox et al, 2008, 2010). 
 Redness of the eye  
 Blurred vision  
 Photophobia (sensitivity to light)  
 Dark, floating spots in the vision 
 Eye pain 
 Table 2 Symptoms Evident in Acute Anterior Uveitis (AAU) 
 
Medical Management  
Examinations and Tests 
A comprehensive ocular and systemic medical history, including family history, is 
essential.  The history will inform a decision to investigate and the choice of tests 
to be undertaken (Andrews and Lightman, 2008; Kanski 2010).  In recurrent 
episodes laboratory tests to distinguish between uveitic entities associated with 
HLA-B27 and those which are not may be included. Confirmation of the HLA-B27 
status in an otherwise fit and healthy person may spare further investigation 
(Andrews and Lightman, 2008; Kanski 2010).  Whenever there is suspicion of an 
associated systemic disease, appropriate referral is required.  Vision assessment 
and slit lamp eye examination are essential in formulating an accurate diagnosis.  
Any suspected case of Uveitis should be referred to an ophthalmologist within 24 
hours (Andrews and Lightman, 2008; Kanski 2010).  
Treatment     
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Medical management of AAU involves the use of topical or systemic 
corticosteroids and topical cycloplegics.  Occasionally, in recalcitrant or 
noncompliant cases and when the posterior segment is also involved 
(panuveitis), subconjunctival injections of cortiocosteroid and Mydricaine No 2 
will be used.  Other immunosuppressive therapy may become necessary in 
refractory cases. Topical corticosteroids have been the mainstay of Uveitis 
therapy but should be used with caution and prudently due to their side effects 
such as cataract formation and glaucoma.  The primary goal in managing the 
disease and minimising complications is the elimination of all inflammatory cells 
from the inner eye.  However the minimum amount of corticosteroids necessary 
should be used to control inflammation whilst preventing complications due to the 
side effects associated with corticosteroid therapy. 
Pain and photophobia caused by spasm of the iris muscle is relieved by 
cycloplegics. Cycloplegics also prevent the development of synechiae which are 
fibrinous adhesions between the iris and the lens which affects the movement of 
the iris.  Short acting dilating drops such as 1% Cyclopentolate Hydrochloride or 
1 % Tropicamide work well and are generally used.  These medications allow for 
the rapid recovery of pupillary function once the medication is discontinued.  
Longer acting cycloplegics are sometimes prescribed such as 1% Atropine or 2% 
Homatropine in some refractory cases.  Patients prefer to wear dark spectacles 
to block out glare caused by the inflammation and the dilating drops.  Some 
cycloplegics paralyse the ciliary muscle and interfere with near vision.  Patients 
must be reminded that the treated eye will have a larger pupil than the other and 
that their vision will be blurred. 
In some cases inflammation continues to recur following weaning of steroids.  In 
these instances, nonsteroidal anti-inflammatory medications (NSAIDS) may be 
prescribed.  Use of NSAIDS requires regular monitoring of liver and kidney 
function.  Patients should be cautioned that they may need added medication to 
protect against the development of stomach ulcers. 
Intermediate and Posterior Uveitis and Panuveitis 
Pars planitis is often painless and the only symptom the patient may be aware of 
is sudden onset of floaters in their vision. Vision will only be noticably affected if 
there is associated oedema of the macula.  There may be minimum signs of 
inflammation in the anterior segment of the eye.  Pars planitis is treated with oral 
steroids or other medications to suppress the immune system.   
Choroiditis (posterior Uveitis) and panuveitis require determination of the 
underlying cause, and treatment of the underlying disease. Symptoms include 
decreased vision, floaters and patchy vision.  The underlying disease may be 
serious. Additional specialists in infectious disease or autoimmunity may be 
needed for such diseases as syphilis, tuberculosis, AIDS, sarcoidosis, or 
Behcet's syndrome. 
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For systemic infectious diseases, corticosteroids are often used along with 
antibiotic therapy. For autoimmune diseases, various forms of suppression of the 
immune system may be required.  Classic AAU generally resolves completely 
when promptly and aggressively treated however in chronic anterior Uveitis 
(CAU) low level inflammation is ongoing requiring prolonged treatment with 
steroid eye drops which can lead to the development of cataract and glaucoma 
particularly when inadequately managed.  In instances where additional 
immunosuppressive treatment is required, immunosuppressive chemotherapy 
medications or immunomodulatory therapy (IMT) may be implemented.  
Medications within the regimine include Methotrexate, CellCept, Imuran, 
Cytoxan, Leukeran and Cyclosporin.  In all cases the medication prescribed 
should be that which has the least potential for side effects.  The use of these 
medications requires regular blood monitoring to ensure that side effects do not 
develop. 
Prognosis     
Classic AAU will resolve completely when treated promptly and aggressively 
(DoH, 2006; Di Lorenzo, 2008; Cox et al, 2010; Kanski, 2010).  However, 
relapses are common; particularly in cases in which the patient is HLA-B27 
positive.  In posterior uveitis, the inflammation may last from months to years and 
may cause permanent vision damage, even with treatment.   
Possible Complications are shown in Table 3.  
 Glaucoma 
 Cataracts  
 Fluid within the retina  
 Retinal detachment  
 Vision loss 
Table 3 Complications Associated with Uveitis 
Ankylosing Spondylitis 
Ankylosing spondylitis is an autoimmune disease that typically affects males 
between the age of 20 – 40 that are HLA-B27 positive.  These individuals are 
seronegative for the rheumatoid factor.  Initial symptoms include early morning 
stiffness or lower back pain (aching).  Symptoms improve with activity.  In 
advanced cases, bony ankylosis causes fixed flexion of the spine and in some 
patients cardiovascular complications are evident.  The primary cardiovascular 
complication is the development of aortic incompetence which is diagnosed with 
ECHO.  Patients with this condition frequently have a soft systolic murmur that 
can be heard with a stethoscope under the left arm (Cox, 2010).  In the female, 
Ankylosing spondylitis is generally more benign.  In children, Ankylosing 
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spondylitis frequently presents with a peripheral lower limb arthropathy in which 
back pain is absent (Kanski, 2007).  Some patients also have ulcerative colitis or 
Crohn’s disease as well as episodes of AAU or chronic Uveitis. 
Crohn’s Disease 
Crohn’s disease is a HLA-B27 positive disease which is chronic, relapsing and 
characterized by multifocal granulomas that generally involve the terminal ileum 
and anorectal components of the intestine (Kanski, 2007).  Crohn’s usually 
affects young adults and may be referred to as granulomatous ileocolitis, terminal 
ileitis or regional ileitis.  Other sections of the gastrointestinal tract that may be 
involved include the oropharynx, oesophagus, stomach and jejunum.  
Manifestations of the disease include episcleritis, acute and or chronic Uveitis, 
low-grade fever, weight loss, arthritis, psoriasis, erythema nodosum, and liver 
disease.  Ocular involvement occurs in approximately 10% of patients with 
Crohn’s disease (Kanski, 2007).  When Crohn’s disease is associated with 
arthritis, the occurance of AAU is increased by 2% - 30% (Kanski, 2007).  
Case Study 
 
Marion (pseudonym) experienced her first case of Uveitis at the age of 27.  
Marion had been painting her lounge window frames with oil based paint.  After 
two days of using the paint Marion noticed a dull ache in her left eye.  She 
thought nothing of it.  ‘Just a headache coming on from all of the paint fumes’ 
Marion thought.  The following morning Marion arose early.  She noticed the 
ache was worse in her left eye.  As she brushed some hair away from eyes her 
hand accidently put pressure on her left eye.  This action caused a severe pain to 
shoot to the back of her eye.  Marion quickly turned on the light to see what had 
happened to her eye.  The glare caused an excruciating pain to shoot to the back 
of her eye.  She cried out in pain and switched off the light.  Marion knew that 
she had to go to the hospital.  However she could not maneuver in the dark to 
get dressed and she could not tolerate the light.  The pain was making her 
physically ill.  Feeling totally incapacitated, Marion went back to bed praying that 
the pain would ease.  The pain only persisted and worsened. Finally, out of 
desperation, Marion called her father and asked him to take her to the hospital. 
 
By the time Marion reached the hospital she could not see anything from her left 
eye.  Upon history taking it emerged that her father and grandfather both suffered 
with what Marion thought might be a similar eye problem.  They both had Uveitis 
and had been treated at the hospital episodically for many years.  A blood test 
revealed that Marion was HLA-B27 positive. 
 
Marion is 37 now.  Over the years she has learned to manage her condition fairly 
well.  Until the past two years Marion experienced 3 to 4 cases of Uveitis per 
year; only in her left eye.  However for the past two years Marion has been 
experiencing Uveitis in both eyes and over the past 6 months has not been able 
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to stop using steriod drops for more than 2 to 3 weeks.  Shortly after the drops 
are weaned off the Uveitis returns.  A decision has been taken to administer 
intraocular steroid injections. 
 
Over the years of being treated Marion has lost confidence in the nurses who 
triage her at the hospital.  Marion would prefer not to be seen by the nurses.  
Marion always presents with photophobia and pain.  However on each 
presentation, the nurses test her vision and shine a bright light in her eyes before 
she is given eye drops that decrease the pain.  Marion would prefer to be given 
the medication that decreases the pain and stops her light sensitivity before they 
shine the light in her eyes.  Marion also feels it is unnecessary to test her vision 
and that it is abusive to shine the light in her eyes.  Marion would like to know 
why her vision is tested by the nurses when she has told them that she can’t see.  
The doctors do not shine a light in her eyes before they have been ‘dilated’ and 
also don’t test her vision.  The doctors understand that she can’t see and take 
her word for it.  Marion also does not understand why the nurses look at her eyes 
with a slit lamp and check the pressure in her eyes when the doctors do the 
same thing.  It seems like a waste of time having it done twice; especially when 
the nurses do not appear to do anything with the information they gain from 
checking her eyes.  
 
Recently Marion mentioned to one of the doctors at the hospital that she has 
been loosing weight.  Marion is having frequent diarrhea and her stool has 
become bloody.  Marion has been referred for Crohn’s disease assessment.   
 
Issues to Consider 
 
Does Marion need any teaching about intraocular injections?  If yes, who should 
provide this teaching? 
 
Why do you think Marion has lost confidence in the nurses who triage her when 
she presents with Uveitis? 
 
Should it be explained to Marion about why nurses test her vision and check her 
pupils with a bright light?  If yes, who should provide this explanation? 
 
Marion has been having recurrent bouts of Uveitis and has been loosing weight.  
Should her HLA-B27 positivity have alerted clinicians to the potential of Marion 
developing Crohn’s disease?  If yes, who should have anticipated this 





Patients with chronic Uveitis generally know when a flare-up is developing and 
may present with a complaint of ‘grumbling pain’ whilst demonstrating only 
HLA-B27 Positivity: associated health implications 
 11 
minimal signs on slit lamp examination.  Subsequently it is possible for there to 
be a delay in the commencement of treatment as Uveitic patients frequently have 
minimal cells present on slit lamp examination when their condition is in 
remission.  Alternatively some patients do not present early as they adopt a self 
diagnosis and treatment approach with the consent of their ophthalmologist. 
These patients must ensure they are seen as early as possible to confirm 
diagnosis, monitor intraocular pressure and response to medications. 
 
Ophthalmic Care Provided by the Nurse 
 
Nurses in many eye hospitals independently manage emergency care for 
patients that have Uveitis (‘see and treat’).  In relation to AAU there are issues 
about access to timely and appropriate care, prescribing treatment and referral.  
In Primary Care, nurses will see patients that have suspected Uveitis.  Nurses 
managing such patients need to regard the red eye with a high note of caution 
and refer to an ophthalmic facility promptly if the patient has a photophobia or 
complains of an aching type pain in their eye.  If eye pain or reduced vision is 
present, this condition is more urgent than if symptoms are very mild.  Nurses 
must ensure that patients understand when AAU occurs this must be treated as 
an ophthalmic emergency. 
 
Nurses engaged in assessment and diagnosis should question patients about 
symptoms reflecting autoimmune diseases when they are assessing associated 
Uveitis. In instances where an autoimmune disease like Ankylosing spondylitis or 
Crohn’s disease is present or suspected, guidance must be provided in relation 
to the pre-disposition to uveitic conditions.   
 
Conclusion  
This article has presented a discussion associated with the causes, 
symptomatology and medical management of the HLA-B27 positive autoimmune 
disorder, Uveitis.  Ankylosing spondylitis and Crohn’s disease were considered 
as they are two types of HLA-B27 positive diseases that demonstrate a link to 
Uveitis.   It was noted that patients who are HLA-B27 positive who present with 
Ankylosing spondylitis or Crohn’s disease may be unaware they are predisposed 
to the development of Uveitis.  It was further indicated that in relation to 
assessment and diagnosis it is essential that the medical history of the patient is 
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Anatomy of the Eye (We will need to get another drawing as this has been taken 














The possession of HLA-B27 positivity 
is not mandatory for autoimmune 
diseases such as Uveitis to occur 
however HLA-B27 positivity not only 
makes it more likely but may modify the 







HLA-B27 positivity increases the 
likelihood of developing: 
a) inflammatory bowel disease 
b) Crohn’s disease 
c) Ulcerative colitis 
d) Reiter’s syndrome 
Answer: 
 
B and C 
C and D 
A, B, and C 
A, B, C and D 
All HLA-B27 positive patients that have 
Uveitis will be aware that they have 






The predisposition toward HLA-B27 
positivity is evident in some family 







The predictive positivity of an allele 
known to confer risk for disease in 
relation to a blood relative of a patient 
with Uveitis has not as yet been 
formally established, however research 
into families with HLA-B27 associated 
Uveitis may provide some useful 
guidelines that can be used to advise 
patients and their families about Uveitis 






Uveitis can be caused by a number of 
autoimmune diseases including: 
 
a) rheumatoid arthritis 
b) ankylosing spondylitis 
c) infection 




a, b, and c 
c and d 
a, b, c and d 
AAU involves inflammation that is 









Pars planitis usually occurs in young 
men, age 20 to 40 and is has been 






Uveitis can be associated with: 
a) Chlamydial infection 
b) Bacillary dysentery 
(Gram-negative organisms 
including Shigella, Salmonella, 
Campylobacter, Klebsiella and 
Yersinia species.) 
c) Toxoplasmosis  
d) CMV retinitis or other 
cytomegalovirus infection  
e) Kawasaki disease  




a through d 
 
b through f 
 
a through f 
 
c through f 
AAU usually runs a short course of 
between 4 to 12 weeks and has a 
tendency to affect the same eye 
especially in patients that are HLA-B27 







Symptoms evident in Uveitis include, 
redness of the eye, blurred vision, 
photophobia, dark floating spots in the 






In instances where additional 
immunosuppressive treatment is 
required to treat Uveitis, 
immunosuppressive 
immunomodulatory therapy is 









The possession of HLA-B27 positivity 
is not mandatory for autoimmune 
diseases such as Uveitis to occur 
however HLA-B27 positivity not only 
True 
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makes it more likely but may modify the 
clinical picture in which a patient 
presents. 
HLA-B27 positivity increases the 
likelihood of developing: 
e) inflammatory bowel disease 
f) Crohn’s disease 
g) Ulcerative colitis 
h) Reiter’s syndrome 
A, B, C and D 
All HLA-B27 positive patients that have 
Uveitis will be aware that they have 
associated systemic disease.   
False 
The predisposition toward HLA-B27 
positivity is evident in some family 
groups with a ratio of male to female 
5:1. 
False 
The predictive positivity of an allele 
known to confer risk for disease in 
relation to a blood relative of a patient 
with Uveitis has not as yet been 
formally established, however research 
into families with HLA-B27 associated 
Uveitis may provide some useful 
guidelines that can be used to advise 
patients and their families about Uveitis 
and associated sequelae 
True 
Uveitis can be caused by a number of 
autoimmune diseases including: 
 
e) rheumatoid arthritis 
f) ankylosing spondylitis 
g) infection 
exposure to toxins 
a, b, c and d 
AAU involves inflammation that is 
usually limited to the iris and ciliary 
body. 
True 
Pars planitis usually occurs in young 
men, age 20 to 40 and is has been 
associated Crohn's disease. 
True 
Uveitis can be associated with: 
a) Chlamydial infection 
b) Bacillary dysentery (Gram-
negative organisms including 
Shigella, Salmonella, 
a through f 
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Campylobacter, Klebsiella and 
Yersinia species.) 
c) Toxoplasmosis  
d) CMV retinitis or other 
cytomegalovirus infection  
e) Kawasaki disease  
f) Herpes zoster infection  
 
AAU usually runs a short course of 
between 4 to 12 weeks and has a 
tendency to affect the same eye 
especially in patients that are HLA-B27 
positive however it is known to affect 
both eyes. 
True 
Symptoms evident in Uveitis include, 
redness of the eye, blurred vision, 
photophobia, dark floating spots in the 
vision and eye pain. 
True 
In instances where additional 
immunosuppressive treatment is 
required to treat Uveitis, 
immunosuppressive 
immunomodulatory therapy is 
contraindicated.   
False 
 
 
 
 
